Xenon Pharmaceuticals Inc (XENE) insider trading
Every open-market stock purchase and sale by Xenon Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $20.9M over the last 12 months (11 sales). No open-market buys.
- Last insider buy: Christopher John Kenney (C-suite exec), $20.2K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $20.9M (11 sales). Last close $51.21 on Jun 7, 2026.
Recent XENE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 5, 2026 | Gary Patou (Insider) | Sold | $70.3K |
| Jun 5, 2026 | Gillian Cannon (Insider) | Sold | $63.2K |
| Jun 3, 2026 | Gillian Cannon (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Gillian Cannon (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Dawn Svoronos (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Steven Gannon (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Steven Gannon (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Dawn Svoronos (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Patrick Machado (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Gary Patou (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Gary Patou (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Patrick Machado (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Elizabeth A. Garofalo (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Justin D. Gover (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Elizabeth A. Garofalo (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Justin D. Gover (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Dawn Svoronos (Insider) | Sold (not open market) | $75.6K |
| Jun 1, 2026 | Steven Gannon (Insider) | Sold (not open market) | $75.6K |
| Jun 1, 2026 | Dawn Svoronos (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Justin D. Gover (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Elizabeth A. Garofalo (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Gary Patou (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Steven Gannon (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Gillian Cannon (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Patrick Machado (Insider) | Bought (not open market) | — |
Who's trading XENE
- Gillian Cannon, Insider: sold $63.2K (1 sale), last Jun 5, 2026
- Gary Patou, Insider: sold $70.3K (1 sale), last Jun 5, 2026
- Patrick Machado, Insider: other filings, last Jun 3, 2026
- Dawn Svoronos, Insider: other filings, last Jun 3, 2026
- Steven Gannon, Insider: other filings, last Jun 3, 2026
- Elizabeth A. Garofalo, Insider: other filings, last Jun 3, 2026
- Justin D. Gover, Insider: other filings, last Jun 3, 2026
- Ian Mortimer, CEO: sold $20.3M (17 sales), last Mar 13, 2026
- Andrea DiFabio, C-suite exec: sold $231K (2 sales), last Mar 13, 2026
- Christopher John Kenney, C-suite exec: sold $244K (2 sales), last Mar 13, 2026
- Darren S Cline, C-suite exec: other filings, last Jan 9, 2026
- Thomas Patrick Kelly, CFO: other filings, last Oct 15, 2025
Get free alerts when an insider at Xenon Pharmaceuticals Inc files a new trade →